Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lidocaine epidermal growth factor receptor small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.04 approved,vet_approved antagonist
lidocaine alpha-1-acid glycoprotein 1 small molecule NA drugbank Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,vet_approved unknown
lidocaine alpha-1-acid glycoprotein 2 small molecule NA drugbank Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,vet_approved unknown
lidocaine sodium channel protein type 10 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.31 approved,vet_approved inhibitor,blocker
lidocaine sodium channel protein type 10 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.31 approved,vet_approved inhibitor
lidocaine voltage-gated sodium channel alpha nav1.9 NA Successful target TTD , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved blocker
lidocaine voltage-gated sodium channel alpha nav1.9 NA Successful target TTD , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved unknown
lidocaine sodium channel protein type 4 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.12 approved,vet_approved blocker
lidocaine sodium channel protein type 5 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.49 approved,vet_approved inhibitor,blocker
lidocaine sodium channel protein type 5 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.49 approved,vet_approved inhibitor
lidocaine sodium channel protein type 9 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.35 approved,vet_approved inhibitor,blocker
lidocaine sodium channel protein type 9 subunit alpha small molecule NA drugbank , DGIDB Brachial plexus structure[MeSHID:D001917]
Nerve Tissue[MeSHID:D009417]
Peripheral Nerves[MeSHID:D010525]
Dysmenorrhea[MeSHID:D004412]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.35 approved,vet_approved inhibitor
click here to return to the previous page